These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16541506)

  • 1. Treating HIV is rarely an emergency. An interview with Joseph Sonnabend. Interview by Bob Huff.
    Sonnabend J
    GMHC Treat Issues; 2005; 19(9-11):10-5. PubMed ID: 16541506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A kinder, gentler approach to treatment. Interview by Paul Simmons.
    Mauss S
    Res Initiat Treat Action; 1998 Aug; 4(5):3-5. PubMed ID: 11365708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New HHS guidelines outline HIV/AIDS treatment strategies.
    AIDS Policy Law; 2004 Nov; 19(21):1, 4. PubMed ID: 15614947
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV research overview: interview with David Ho, M.D. Interview by John S. James.
    Ho D
    AIDS Treat News; 1997 Nov; (No 282):1-6. PubMed ID: 11364903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arriving too soon: suggestions for the coming generation of "heavily treated" patients.
    Simmons P
    Res Initiat Treat Action; 2000 Sep; 6(3):5-6. PubMed ID: 11708166
    [No Abstract]   [Full Text] [Related]  

  • 7. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
    Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
    Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating HIV: when to start, who should treat, and still missing many.
    Laurence J
    AIDS Read; 2008 Jun; 18(6):285-6. PubMed ID: 18623889
    [No Abstract]   [Full Text] [Related]  

  • 9. A guide for understanding the guidelines.
    Sharp M
    Posit Aware; 2004; 15(1):43-5. PubMed ID: 14989197
    [No Abstract]   [Full Text] [Related]  

  • 10. To start or not to start?
    Learned J
    Posit Aware; 2001; 12(5):28-9. PubMed ID: 11688482
    [No Abstract]   [Full Text] [Related]  

  • 11. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
    AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
    Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
    J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
    Cozzi-Lepri A; Phillips AN; Ruiz L; Clotet B; Loveday C; Kjaer J; Mens H; Clumeck N; Viksna L; Antunes F; Machala L; Lundgren JD;
    AIDS; 2007 Mar; 21(6):721-32. PubMed ID: 17413693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV agents. Is FOTO a treatment interruption that works?
    TreatmentUpdate; 2005; 17(5):10-1. PubMed ID: 17219661
    [No Abstract]   [Full Text] [Related]  

  • 15. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
    J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIO study's novel combination shows promise.
    Dalton P
    Proj Inf Perspect; 2008 Sep; (46):7. PubMed ID: 19043875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
    Izopet J; Marchou B; Charreau I; Sauné K; Tangre P; Molina JM; Aboulker JP;
    Antivir Ther; 2008; 13(4):537-45. PubMed ID: 18672532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

  • 20. Interviews and anecdotal reports.
    Posit Health News; 1998; (No 16):13-5. PubMed ID: 11365012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.